Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients

Lennart J. Blom*, Marloes Visser, Imke Christiaans, Marcoen F. Scholten, Marianne Bootsma, Maarten P. van den Berg, Sing-Chien Yap, Jeroen F. van der Heijden, Pieter A. Doevendans, Peter Loh, Pieter G. Postema, Daniela Q. Barge-Schaapsveld, Nynke Hofman, Paul G. A. Volders, Arthur A. Wilde, Rutger J. Hassink

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1519-1526
Number of pages8
JournalEP Europace
Volume21
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • Idiopathic ventricular fibrillation
  • Ventricular arrhythmia
  • Implantable cardioverter-defibrillator
  • Implantable cardioverter-defibrillator therapy
  • primary electrical disease
  • PROLONGED PR INTERVAL
  • TERM-FOLLOW-UP
  • MANAGEMENT
  • ABLATION
  • OUTCOMES

Cite this